Phanquinone
Chemical compound
- P01AX04 (WHO) QP51AX03 (WHO)
- 4,7-phenanthroline-5,6-dione
- 84-12-8
N
- 6764
- 6506
Y
- ID94IS6N8J
- D07359
Y
- CHEBI:59141
Y
- ChEMBL531048
Y
- DTXSID3046112
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- O=C3c1ncccc1c2c(nccc2)C3=O
InChI
- InChI=1S/C12H6N2O2/c15-11-9-7(3-1-5-13-9)8-4-2-6-14-10(8)12(11)16/h1-6H
Y
- Key:VLPADTBFADIFKG-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Phanquinone is an organic compound. It is a yellowish solid derived by oxidation of 4,7-phenanthroline.[citation needed]
It has been investigated as both antiprotozoal agent and for its bactericidal activity .[1]
References
- ^ Mett H, Gyr K, Zak O, Vosbeck K (July 1984). "Duodeno-pancreatic secretions enhance bactericidal activity of antimicrobial drugs". Antimicrob. Agents Chemother. 26 (1): 35–8. doi:10.1128/aac.26.1.35. PMC 179912. PMID 6236746.
- v
- t
- e
Tissue amebicides |
| ||||||
---|---|---|---|---|---|---|---|
Luminal amebicides |
| ||||||
Other/ungrouped |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e